Home >> Healthcare >> Dengue Vaccines Market

Global Dengue Vaccines Market Size,Trends, Growth Forecast to 2031

Category : Healthcare | Report Code : 463 | Pages : 141 | Oct 2024

Report Overview

Dengue vaccine is a vaccine used to prevent dengue fever in humans. As of 2019, one version is commercially available, known as CYD-TDV, and sold under the brand name Dengvaxia. The vaccine is only recommended in those who have previously had dengue fever or populations in which most people have been previously infected. The value of the vaccine is limited by the fact that it may worsen outcomes in those who have not previously been infected. It is given as three injections over a year.

The global Dengue Vaccines market size is projected to grow from US$ 512 million in 2024 to US$ 1174 million in 2030; it is expected to grow at a CAGR of 14.8% from 2024 to 2030.

LPI (LP Information)' newest research report, the “Dengue Vaccines Industry Forecast” looks at past sales and reviews total world Dengue Vaccines sales in 2022, providing a comprehensive analysis by region and market sector of projected Dengue Vaccines sales for 2023 through 2029. With Dengue Vaccines sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Dengue Vaccines industry.

This Insight Report provides a comprehensive analysis of the global Dengue Vaccines landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Dengue Vaccines portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Dengue Vaccines market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Dengue Vaccines and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Dengue Vaccines.

The only one version which is commercially available now, known as Dengvaxia and produced by Sanofi, don't has enough efficacy. While there are several vaccines are on trial now. TAK-003, developed by Takeda is one stride closer to reaching the sizable market waiting for dengue vaccines as it reports positive top-line results from a massive Phase III trial.

This report presents a comprehensive overview, market shares, and growth opportunities of Dengue Vaccines market by product type, application, key players and key regions and countries.

Segmentation by Type:
    Dengvaxia
    TAK-003
    Others

Segmentation by Application:
    Public Sector
    Private Sector

This report also splits the market by region:
    Americas
        United States
        Canada
        Mexico
        Brazil
    APAC
        China
        Japan
        Korea
        Southeast Asia
        India
        Australia
    Europe
        Germany
        France
        UK
        Italy
        Russia
    Middle East & Africa
        Egypt
        South Africa
        Israel
        Turkey
        GCC Countries

Segmentation by Type:
    Dengvaxia
    TAK-003
    Others

Segmentation by Application:
    Public Sector
    Private Sector

This report also splits the market by region:
    Americas
        United States
        Canada
        Mexico
        Brazil
    APAC
        China
        Japan
        Korea
        Southeast Asia
        India
        Australia
    Europe
        Germany
        France
        UK
        Italy
        Russia
    Middle East & Africa
        Egypt
        South Africa
        Israel
        Turkey
        GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
    Sanofi
    Takeda

Frequently Asked Questions?

Ans - The purpose of a Dengue Vaccines market research report is to provide data-driven insights and analysis on a Dengue Vaccines market. It helps businesses understand industry trends, competition, consumer behavior, market size, growth potential, and risks, supporting strategic decision-making.

Ans - Market research reports typically include both quantitative (market size, revenue, growth rates) and qualitative (trends, consumer preferences, competitive analysis) data. It often includes industry statistics, surveys, expert opinions, historical data, and future forecasts.

Ans - The forecast period typically for Dengue Vaccines market report spans the next 5 to 10 years. It includes projected market trends, growth opportunities, and potential challenges.

Ans - Yes, Analytic Insights Hub customization services, allowing businesses to focus on specific geographies, sectors, or market segments that are relevant to them.

Ans - The report highlights major trends such as technological innovations, consumer behavior shifts, regulatory changes, or emerging markets that may impact the industry?s growth.